Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Synchrony
SYF
|
+$683M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$485M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$394M |
| 4 |
Apple
AAPL
|
+$378M |
| 5 |
Bausch Health
BHC
|
+$280M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DuPont de Nemours
DD
|
+$805M |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$603M |
| 3 |
GE Aerospace
GE
|
+$548M |
| 4 |
iShares MSCI Emerging Markets ETF
EEM
|
+$426M |
| 5 |
Gilead Sciences
GILD
|
+$313M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 87.2% |
| 2 | Technology | 3.05% |
| 3 | Financials | 2.16% |
| 4 | Consumer Discretionary | 1.64% |
| 5 | Communication Services | 1.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2526
PUT
ProShares Ultra Materials
UYM
$41.7M
| $4.96M | ﹤0.01% |
548,400
+252,000
| +85% | +$2.37M |
|
2527
Novavax
NVAX
$1.53B
| $4.96M | ﹤0.01% |
29,556
+10,992
| +59% | +$1.69M |
|
2528
PUT
Enanta Pharmaceuticals
ENTA
$396M
| $4.96M | ﹤0.01% |
150,100
+129,800
| +639% | +$4.23M |
|
2529
iShares MSCI India ETF
INDA
$6.61B
| $4.96M | ﹤0.01% |
179,911
-207,020
| -54% | -$5.78M |
|
2530
Zoetis
ZTS
$32B
| $4.95M | ﹤0.01% |
103,396
-26,107
| -20% | -$1.18M |
|
2531
PUT
Centene
CNC
$32B
| $4.95M | ﹤0.01% |
150,400
-174,200
| -54% | -$5.16M |
|
2532
Hartford Financial Services
HIG
$37.5B
| $4.95M | ﹤0.01% |
113,887
-99,244
| -47% | -$4.55M |
|
2533
CALL
Prologis
PLD
$134B
| $4.94M | ﹤0.01% |
115,100
-21,600
| -16% | -$911K |
|
2534
PUT
Copa Holdings
CPA
$5.29B
| $4.94M | ﹤0.01% |
102,300
+66,500
| +186% | +$3.46M |
|
2535
PUT
Interactive Brokers
IBKR
$43.4B
| $4.94M | ﹤0.01% |
452,800
+96,800
| +27% | +$1.01M |
|
2536
iShares MSCI Taiwan ETF
EWT
$11.7B
| $4.93M | ﹤0.01% |
193,131
-1,085,442
| -85% | -$29.7M |
|
|
AFAM
2537
CALL
DELISTED
Almost Family Inc
AFAM
| $4.93M | ﹤0.01% |
128,900
+16,600
| +15% | +$672K |
|
2538
Universal Health Services
UHS
$10.1B
| $4.92M | ﹤0.01% |
41,216
+21,009
| +104% | +$2.57M |
|
|
JUNO
2539
CALL
DELISTED
Juno Therapeutics, Inc.
JUNO
| $4.92M | ﹤0.01% |
112,000
-100,100
| -47% | -$4.96M |
|
2540
Intuit
INTU
$97.9B
| $4.92M | ﹤0.01% |
50,958
-73,683
| -59% | -$7.12M |
|
|
CAVM
2541
PUT
DELISTED
Cavium, Inc.
CAVM
| $4.92M | ﹤0.01% |
74,800
-109,900
| -60% | -$7.42M |
|
2542
CALL
iShares Core S&P Mid-Cap ETF
IJH
$124B
| $4.91M | ﹤0.01% |
174,500
-230,000
| -57% | -$6.57M |
|
|
TPCO
2543
DELISTED
Tribune Publishing Company Common Stock
TPCO
| $4.91M | ﹤0.01% |
532,274
-215,360
| -29% | -$2.02M |
|
|
IDTI
2544
CALL
DELISTED
Integrated Device Technology I
IDTI
| $4.91M | ﹤0.01% |
186,200
+3,800
| +2% | +$97.4K |
|
|
MHFI
2545
PUT
DELISTED
MCGRAW-HILL FINANCIAL INC COM
MHFI
| $4.9M | ﹤0.01% |
49,700
-28,900
| -37% | -$2.74M |
|
2546
Cogent Communications
CCOI
$486M
| $4.9M | ﹤0.01% |
141,196
+28,570
| +25% | +$923K |
|
|
PX
2547
PUT
DELISTED
Praxair Inc
PX
| $4.89M | ﹤0.01% |
47,800
-37,100
| -44% | -$4.05M |
|
2548
PUT
Sempra
SRE
$55.1B
| $4.89M | ﹤0.01% |
104,000
-6,400
| -6% | -$316K |
|
2549
Assurant
AIZ
$14.1B
| $4.89M | ﹤0.01% |
60,678
+40,301
| +198% | +$3.32M |
|
|
OPLN
2550
Openlane
OPLN
$4.28B
| $4.88M | ﹤0.01% |
348,498
+278,485
| +398% | +$3.94M |
|
Similar funds
Jeff Yass's Q4 2015 Portfolio in Review
As of Q4 2015, Jeff Yass held 10,716 positions worth $216B, down 6.4% from $231B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Jeff Yass's Q4 2015 filing shows 1,138 new, 3,488 increased, 4,567 reduced and 1,373 closed positions. Its largest new stake was Alphabet (Google) Class A: 13,098,340 shares worth $510M. The largest sale was DuPont de Nemours, an estimated $805M.
By sector, the portfolio is most concentrated in Miscellaneous at 87% of assets, down from 87% a quarter earlier, followed by Technology and Financials.
- Jeff Yass's largest Q4 2015 buy was Alphabet (Google) Class A: 13,098,340 shares worth $510M.
- Jeff Yass added most to Synchrony in Q4 2015, an estimated $683M increase.
- Jeff Yass's biggest Q4 2015 reduction was DuPont de Nemours, cutting an estimated $805M.
- Jeff Yass fully exited Altera Corp in Q4 2015, selling an estimated $97.3M.
- Jeff Yass's ten largest holdings make up 21% of its $216B portfolio in Q4 2015.
- Jeff Yass opened 1,138 new positions and closed 1,373 in Q4 2015.
- Jeff Yass's portfolio value fell 6.4% quarter-over-quarter to $216B.
Based on Susquehanna International Group's 13F filing for Q4 2015, filed 16 Feb 2016.